Informational purposes only, not investment advice.
EFAD (EFAD)
tormere.com/research/EFAD · generated 2026-10-28
$45.67
+0.12%
General Information
Price$45.67
Change+0.12%
Market Cap—
Sector—
Industry—
Exchange—
Beta (raw, 60mo vs SPY)0.70
Signals
Insider Velocity—
Congress Trades (90d)—
Short Volume
1% of daily vol
Conviction Score—
Price Chart (1 Year)
Recent News
(EFAD) Movement Within Algorithmic Entry Frameworks — Stock Traders Daily · 2026-10-25
Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement — The Lancet · 2026-07-08
Tormere — informational purposes only, not investment advice.
